Most of these can be considered mild and transient, and are typically managed with medications like proton pump inhibitors as well as counseling patients on changing behaviors (e.g., eating smaller meals more often, avoiding spicy food) [2]
If tirzepatide's dual-agonist approach interests you, check does tirzepatide burn fat for a mechanistic comparison
You are free to explore the full analysis and discover what other signals might be shaping this industry's transformation (available until April 12): Want to build custom radars for your domain
The two amylin compounds differ on receptor selectivity rather than mechanism class, which we unpack in our cagrilintide vs eloralintide comparison
The A4PC has reinforced this guidance directly to its member compounders
In CDM, semaglutide users generally had greater reductions in clinical outcome risks in patients with a history of stroke, MI, or their composite vs the overall population (Table S8)